erythromycin has been researched along with Aspergillosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukushima, K; Imamura, Y; Izumikawa, K; Kakeya, H; Kohno, S; Kosai, K; Kurihara, S; Miyazaki, T; Miyazaki, Y; Nakamura, S; Saijo, T; Seki, M; Takazono, T; Yamamoto, Y; Yanagihara, K | 1 |
PROCKNOW, JJ | 1 |
Lynch, JP | 1 |
Bren, A; Kandus, A; Koselj, M; Kovac, D | 1 |
1 review(s) available for erythromycin and Aspergillosis
Article | Year |
---|---|
Approach to the immunosuppressed patient with pulmonary infiltrates.
Topics: Aspergillosis; Blastomycosis; Candidiasis; Cryptococcosis; Erythromycin; Fungi; Histoplasmosis; Humans; Immunosuppression Therapy; Legionnaires' Disease; Lung Diseases; Lung Diseases, Fungal; Mycobacterium Infections; Nocardia Infections; Pneumonia; Pneumonia, Pneumocystis; Pneumonia, Viral | 1980 |
1 trial(s) available for erythromycin and Aspergillosis
Article | Year |
---|---|
Drug interactions between cyclosporine and rifampicin, erythromycin, and azoles in kidney recipients with opportunistic infections.
Topics: Adult; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Cyclosporine; Drug Interactions; Erythromycin; Female; Humans; Kidney Transplantation; Legionnaires' Disease; Male; Middle Aged; Opportunistic Infections; Postoperative Complications; Rifampin; Streptococcal Infections; Tuberculosis, Pulmonary | 1994 |
2 other study(ies) available for erythromycin and Aspergillosis
Article | Year |
---|---|
A case of Legionella pneumophila pneumonia followed by invasive aspergillosis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Ciprofloxacin; Erythromycin; Humans; Hydrocortisone; Legionella pneumophila; Legionnaires' Disease; Lung Diseases, Fungal; Male; Middle Aged; Treatment Outcome | 2008 |
Treatment of opportunistic fungus infections.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Erythromycin; Fungi; Gentian Violet; Humans; Iodides; Mycoses; Nystatin; Penicillins; Stilbamidines; Sulfanilamide; Sulfanilamides; Sulfonamides | 1962 |